Department of Biochemistry, Memorial University of Newfoundland
2014-present Full Professor & Head
Department of Chemistry, Brandon University
2014 Full Professor
2010-13 Department Chair
2008-14 Associate Professor
2004-07 Assistant Professor
College of Pharmacy & Nutrition, University of Saskatchewan
2013-present Adjunct Professor
2010-12 Drug Discovery & Development Research Group
Toxicology Centre, University of Saskatchewan
2007-12 Adjunct Professor
ALviva Biopharmaceuticals Inc. (Saskatoon, Saskatchewan)
2003 Senior Scientific Officer
2000-02 Head, Target Identification & Model Development
1999-2000 Senior Research Scientist
Department of Psychiatry, University of Saskatchewan
1999-2004 Adjunct Professor
1996-99 Neuropsychiatry Research Unit, University of Saskatchewan
Supervisor - Dr. A.A. Boulton
1993-95 Department of Pharmacology, Ohio State University
Supervisor - Dr. N.H. Neff
1989-93 Neuropsychiatry Research Unit, University of Saskatchewan
Supervisor - Dr. I.A. Paterson
1986-89 Department of Pharmacology, University of Sunderland
Supervisor - Dr. S.A. Pleece
ORCID ID 0000-0003-0172-0803
*Denotes students from the Berry lab
- 2018 M.J. Cripps, M. Bagnati, T.A. Jones, B.W. Ogunkolade, K. Hanna, K. Fair, C. Nelson, R. Lowe, G.A. Hitman, M.D. Berry, and M.D. Turner
Downregulation of trace amine-associated receptor signalling contributes to glucolipotoxic inhibition of insulin secretion. (in revision)
- 2018 S.L. Christian and M.D. Berry
Trace amine-associated receptors as a novel target for environmental hypersensitivity disorders.
Front. Pharmacol. 9; 680
- 2018 R.R. Gainetdinov, M.D. Berry and M.C. Hoener
Trace amines and their receptors.
Pharmacol. Rev. 70; 549-620
- 2017 M.D. Berry, R.R. Gainetdinov, M.C. Hoener and M. Shahid
Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges.
Pharmacol. Ther. 180; 161-80
- 2016 M.D. Berry, S. Hart*, A. Pryor*, S. Hunter* and D. Gardiner*
Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes.
Sci. Rep. 6; 38006
- 2015 B.W. Holland, M.D. Berry, C.G. Gray and B. Tomberli
A permeability study of O2 and the trace amine p-tyramine through model phosphatidylcholine bilayers.
PLoS One 10; e0122468
- 2013 M.D. Berry, M.R. Shitut*, A. Almousa, J. Alcorn and B. Tomberli
Membrane permeability of trace amines: Evidence for a regulated, activity-dependent, non-exocytotic, synaptic release.
Synapse 67; 656-67
- 2011 M.D. Berry, J. Nickel*, M.R. Shitut* and B. Tomberli
Molecular dynamics-based simulation of trace amine permeability.
J. Neural Transm. 118; 1119-28
- 2011 M.D. Berry
The effects of pargyline and 2-phenylethylamine on D1-like dopamine receptor binding.
J. Neural Transm. 118; 1115-8
- 2016 A. Pryor*, S. Hart* and M.D. Berry
Synthesis and neurochemistry of trace amines. Invited book chapter for Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors (eds. Farooqui, T. and Farooqui, A.A.) pp. 27-43. doi:http://dx.doi.org/10.1016/B978-0-12-803603-7.00003-3
- 2016 M.D. Berry
Trace amines and their receptors in the control of cellular homeostasis. Invited book chapter for Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors (eds. Farooqui, T. and Farooqui, A.A.) pp. 107-123. doi:http://dx.doi.org/10.1016/B978-0-12-803603-7.00008-2
- 2010 M.D. Berry, J. Nickel* and B. Tomberli
Trace amines and their receptors comprise a novel vertebrate aminergic signalling system.
In: Biogenic Amines: Pharmacologic, Neurochemical and Molecular Aspects in the CNS (eds. Farooqui, T. & Farooqui, A.A.) pp. 279-301
- 2012 M.D. Berry
(-)-Deprenyl and related compounds for the treatment of alopecia.
Canadian Provisional Patent Application #61/711,296.
Filed October 9, 2012. PCT full application submitted March 2013